Quin Technology Company

Quin is pioneering a new era of direct-to-consumer Virtual Care 2.0 for diabetes that doesn’t rely on human healthcare professionals. Unlike existing diabetes platforms, which add a digital veneer to already ineffective analogue healthcare models, Quin goes deep into the 24x7 needs of the individual living with the condition. Their groundbreaking personalization model empowers people to better manage on their own, when they’re away from their doctors and living their day-to-day life — where 99.9% of diabetes care actually happens. The first Quin app is a novel digital therapeutic for personalized independent self-management of type 1 diabetes. It regularly ranks in the top #1-3 most-downloaded diabetes apps in the App Store in the UK and Ireland. 96% of Quin users experience better health outcomes or wellbeing, or both. Early data shows a massive opportunity to improve time-in-range (a critical healthcare metric) by 10-20% for those starting at less than 70%.
Industry: mHealth
Headquarters: London, England, United Kingdom
Zip: 11-50
Founded Date: 2014-01-01
Employees Number: 11-50
Funding Status: Seed
Investors Number: 4809277
Total Funding: 4809277
Estimated Revenue: 2022-08-05
Last Funding Date: Convertible Note
Last Funding Type: Convertible Note

Visit Website
https://twitter.com/quindiabetesapp
https://www.crunchbase.com/organization/ayuda-heuristics
Register and Claim Ownership